The page is the record's research on the issuer — no analyst, no rating, no view.

# ARGENX SE (NASDAQ: ARGX) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is ARGENX SE, listed on NASDAQ under ticker ARGX, ISIN US04016X1019, LEI 7245009C5FZE6G9ODQ71. Its security type is recorded as non-operating entity type (other). Its segment is not on the record. Its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is Netherlands. The issuer is listed and not halted.

## The disclosure read

The record holds 38 filings in the twelve months to 2026-11-08, across 32 filing days, of which 26 are results, 6 are regulatory filings and 6 are takeover filings. The median gap between filing days is 8 days. The latest filing is dated 2026-11-05 and is a regulatory filing, 3 days before the record date. The NASDAQ median is 6.0 days between filing days, 52 filings and 5.0 days of latency across 4,359 issuers. The sector median is 5.5 days between filing days, 65.5 filings and 4.0 days of latency across 176 issuers.

## Auditor

The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag, and foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change events. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted.

## Orderability

The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.

## Coverage

No research houses were found on the issuer's own investor-relations page.

## Open research

No openly published research notes are on the record for the issuer.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001697862.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/ARGX (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/ARGX (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ARGX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
